Thomas Powles

Nov 21, 2024 | cell.com | Habib Hamidi |Yasin Senbabaoglu |Niha Beig |Juliette Roels |Cyrus Manuel |Xiangnan Guan | +26 more

Keywordsurothelial carcinomatranscriptomicsmolecular heterogeneityPD-L1 blockadepatient stratificationdigital pathologyGet full text accessLog in, subscribe or purchase for full access. References1. Ishida, Y. ∙ Agata, Y. ∙ Shibahara, K. ... Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell deathEMBO J. 1992; 11:3887-38952. Tang, J. ∙ Yu, J.X. ∙ Hubbard-Lucey, V.M. ...

Nov 4, 2024 | urotoday.com | Thomas Powles

Read the Full Video TranscriptZachary Klaassen: Hi, my name is Zach Klaassen. I'm a urologic oncologist at the Georgia Cancer Center in Augusta, Georgia. I'm delighted to be joined today on UroToday with Tom Powles, who is a medical oncologist at the Barts Cancer Institute. We're going to be discussing ESMO 2024 data, EV-302, an exploratory analysis of nectin-4 expression. Tom, thanks so much for joining us today on UroToday. Thomas Powles: Zach, thank you for inviting me. It's a pleasure to be here.

Nov 4, 2024 | urotoday.com | Thomas Powles

Read the Full Video TranscriptZachary Klaassen: Hi. My name is Zach Klaassen. I'm a urologic oncologist at the Georgia Cancer Center in Augusta, Georgia. I am delighted to be joined today by Dr. Tom Powles, medical oncologist from Barts Cancer Institute in London in the UK. We're going to be talking today about ESMO 2024 data, practice-changing data from NIAGARA. Tom, thanks very much for taking some time to join us today. Thomas Powles: Zach, thank you for inviting me.

Oct 11, 2024 | urotoday.com | Thomas Powles

Read the Full Video TranscriptShilpa Gupta: Hi, everyone. I'm Shilpa Gupta, GU medical oncologist at the Cleveland Clinic, and really delighted to be joined by Dr. Tom Powles from the UK, who will talk to us about EV-302 data he presented at the ESMO meeting 2024. Hi, Tom. Thomas Powles: Hey, Shilpa. How are you? Shilpa Gupta: I'm good. Thanks for joining us, Tom. I know you're very busy. Thomas Powles: Thanks for inviting me.

Oct 11, 2024 | urotoday.com | Thomas Powles

Read the Full Video TranscriptShilpa Gupta: Hi, everyone. I'm Shilpa Gupta, GU medical oncologist at the Cleveland Clinic, and really delighted to be joined by Dr. Tom Powles from the UK, who will talk to us about EV-302 data he presented at the ESMO meeting 2024. Hi, Tom. Thomas Powles: Hey, Shilpa. How are you? Shilpa Gupta: I'm good. Thanks for joining us, Tom. I know you're very busy. Thomas Powles: Thanks for inviting me.